BRPI0509167A - uso das n-(2-aril-propionil)-sulfonamidas para o tratamento de lesões da medula espinhal - Google Patents

uso das n-(2-aril-propionil)-sulfonamidas para o tratamento de lesões da medula espinhal

Info

Publication number
BRPI0509167A
BRPI0509167A BRPI0509167-5A BRPI0509167A BRPI0509167A BR PI0509167 A BRPI0509167 A BR PI0509167A BR PI0509167 A BRPI0509167 A BR PI0509167A BR PI0509167 A BRPI0509167 A BR PI0509167A
Authority
BR
Brazil
Prior art keywords
sulfonamides
treatment
spinal cord
arylpropionyl
cord injuries
Prior art date
Application number
BRPI0509167-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Riccardo Bertini
Francesco Colotta
Original Assignee
Dompe Pha R Ma Spa Res & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Pha R Ma Spa Res & Mfg filed Critical Dompe Pha R Ma Spa Res & Mfg
Publication of BRPI0509167A publication Critical patent/BRPI0509167A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0509167-5A 2004-03-25 2005-03-17 uso das n-(2-aril-propionil)-sulfonamidas para o tratamento de lesões da medula espinhal BRPI0509167A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007177A EP1579859B1 (en) 2004-03-25 2004-03-25 Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
PCT/EP2005/002822 WO2005092315A1 (en) 2004-03-25 2005-03-17 Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury

Publications (1)

Publication Number Publication Date
BRPI0509167A true BRPI0509167A (pt) 2007-09-11

Family

ID=34854609

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509167-5A BRPI0509167A (pt) 2004-03-25 2005-03-17 uso das n-(2-aril-propionil)-sulfonamidas para o tratamento de lesões da medula espinhal

Country Status (23)

Country Link
US (1) US20090030083A1 (enExample)
EP (1) EP1579859B1 (enExample)
JP (1) JP4988550B2 (enExample)
KR (2) KR101327150B1 (enExample)
CN (2) CN103054842A (enExample)
AT (1) ATE347883T1 (enExample)
AU (1) AU2005226901B2 (enExample)
BR (1) BRPI0509167A (enExample)
CA (1) CA2555162C (enExample)
CY (1) CY1107562T1 (enExample)
DE (1) DE602004003673T2 (enExample)
DK (1) DK1579859T3 (enExample)
ES (1) ES2279248T3 (enExample)
IL (1) IL177169A (enExample)
MX (1) MXPA06009085A (enExample)
NO (1) NO20064793L (enExample)
NZ (1) NZ548917A (enExample)
PL (1) PL1579859T3 (enExample)
PT (1) PT1579859E (enExample)
RU (1) RU2396075C2 (enExample)
SI (1) SI1579859T1 (enExample)
WO (1) WO2005092315A1 (enExample)
ZA (1) ZA200608517B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2664359A1 (en) * 2006-09-26 2008-04-03 Case Western Reserve University Cytokine signaling
EP2308484A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
CN103172547B (zh) * 2011-12-20 2016-10-12 天津市国际生物医药联合研究院 磺酰胺衍生物的制备及其应用
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
KR20220064039A (ko) 2020-11-11 2022-05-18 정성삼 척수 손상 예방 또는 치료용 조성물
KR102320780B1 (ko) 2021-01-29 2021-11-02 정성삼 척추 통증 완화 및 척추 유연성 개선을 위한 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US6419944B2 (en) * 1999-02-24 2002-07-16 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
IT1318466B1 (it) * 2000-04-14 2003-08-25 Dompe Spa Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz

Also Published As

Publication number Publication date
DK1579859T3 (da) 2007-04-10
ATE347883T1 (de) 2007-01-15
KR20070018015A (ko) 2007-02-13
KR101327150B1 (ko) 2013-11-06
DE602004003673T2 (de) 2007-10-04
RU2006137575A (ru) 2008-04-27
MXPA06009085A (es) 2007-04-02
ES2279248T3 (es) 2007-08-16
WO2005092315A1 (en) 2005-10-06
NO20064793L (no) 2006-10-23
NZ548917A (en) 2010-06-25
CY1107562T1 (el) 2013-03-13
KR20120104445A (ko) 2012-09-20
KR101312235B1 (ko) 2013-09-26
CA2555162C (en) 2012-11-27
US20090030083A1 (en) 2009-01-29
AU2005226901B2 (en) 2011-06-02
DE602004003673D1 (de) 2007-01-25
IL177169A (en) 2010-12-30
EP1579859A1 (en) 2005-09-28
CA2555162A1 (en) 2005-10-06
AU2005226901A1 (en) 2005-10-06
EP1579859B1 (en) 2006-12-13
RU2396075C2 (ru) 2010-08-10
PT1579859E (pt) 2007-03-30
JP2007530478A (ja) 2007-11-01
SI1579859T1 (sl) 2007-04-30
CN1933825A (zh) 2007-03-21
CN103054842A (zh) 2013-04-24
ZA200608517B (en) 2008-04-30
IL177169A0 (en) 2006-12-10
PL1579859T3 (pl) 2007-06-29
JP4988550B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
CY1110254T1 (el) Φαινυλακεταμιδια και χρησις των ως διαμορφωται γλυκοκινασης
NO20054072D0 (no) Terapeutisk middel for ryggmargsskade omfattende interleukin-6 antagonist.
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
PT1506781E (pt) Composicao para tratamento vaginal
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
SE0301653D0 (sv) Novel compounds
BRPI0606112B8 (pt) 3-hetero-aril-3-hidróxi-2-amino-propil aminas e compostos relacionados com atividade analgésica, uso dos mesmos e composição farmacêutica compreendendo os mesmos
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
CY1107562T1 (el) Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου
UY28344A1 (es) Nuevos compuestos
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
EA200602281A1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
BRPI0810446A2 (pt) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxidopiridin-4-il)- 5-(metóxi)piridina-2-carboxamida para o tratamento de traumas da medula espinhal
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
CY1110796T1 (el) Παραγωγα μορφολινης ως αναστολεις επαναπροσληψης νορεπινεφρινης
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
NO20081080L (no) Nytt salt I
EA200501609A1 (ru) Поддерживающее устройство, предназначенное для использования в качестве опоры кости во время хирургической операции

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DOMPE' S.P.A. (IT)

Free format text: TRANSFERIDO POR FUSAO DE: DOMPE PHA.R.MA S.P.A.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: PAGAR RESTAURACAO.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2260 DE 29/04/2014

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B11T Dismissal of application maintained [chapter 11.20 patent gazette]